Drugs for Gastrointestinal Diseases Practice Questions

Q: Drug that binds bile acids in the intestine and prevents their return to liver via the enterohepatic circulation?

Cholestyramine. ***Cholestyramine*** - **Cholestyramine** is a **bile acid-binding resin** that sequesters bile acids in the intestine, preventing their reabsorption. - This interruption of the **enterohepatic circulation** leads to increased synthesis of new bile acids from cholesterol in the liver, thus lowering plasma LDL cholesterol. *Niacin* - **Niacin (nicotinic acid)** reduces the hepatic synthesis and secretion of **VLDL**, which in turn lowers LDL and triglyceride levels. - It works primarily through mechanisms related to fat metabolism in the liver and adipose tissue, not direct bile acid binding in the intestine. *Fenofibrate* - **Fenofibrate** is a **PPAR-α agonist** that primarily reduces triglyceride levels by increasing fatty acid oxidation and lipoprotein lipase activity, and secondarily increases HDL. - Its main action is on lipid metabolism in the liver and peripheral tissues, not by binding bile acids in the gut. *Gugulipid* - **Gugulipid** is a phytosterol derived from the guggul tree, sometimes used in traditional medicine for cholesterol management. - Its purported mechanism involves increasing **bile acid excretion** and inhibiting cholesterol biosynthesis, but it does not directly bind bile acids in the same manner as resins like cholestyramine.

Q: Which of the following is classified as an antispasmodic agent?

Dicyclomine. ***Dicyclomine*** - **Dicyclomine** is an **anticholinergic** medication that works by blocking muscarinic receptors, thereby reducing smooth muscle spasm in the gastrointestinal tract. - It is commonly used to treat symptoms of **irritable bowel syndrome (IBS)**, such as abdominal pain and cramping. *Physostigmine* - **Physostigmine** is a **cholinesterase inhibitor** that increases the concentration of acetylcholine at the synaptic cleft. - It is used to treat **anticholinergic poisoning** by reversing the effects of anticholinergic drugs, rather than acting as an antispasmodic itself. *Tropicamide* - **Tropicamide** is an **anticholinergic** agent primarily used as a **mydriatic** (pupil dilator) and **cycloplegic** (paralyzes the ciliary muscle) for ophthalmic examinations. - Its action is localized to the eye and it does not have significant systemic antispasmodic effects. *None of the options* - This option is incorrect because one of the listed medications is indeed classified as an antispasmodic agent. - When "None of the options" appears as a choice, it should only be selected if all other options are clearly incorrect.

Q: Which of the following is the most common side effect of Cimetidine?

CNS effects (confusion, dizziness). ***CNS effects (confusion, dizziness)*** - **Cimetidine** is a **H2-receptor antagonist** that can cross the **blood-brain barrier**, leading to **central nervous system (CNS) side effects**. - These effects, including **confusion, dizziness**, and **headache**, are more common in elderly patients or those with renal impairment due to reduced drug clearance. *Impotence* - While **cimetidine** can cause **endocrine effects** due to its anti-androgenic activity, **impotence** is a less common side effect compared to CNS disturbances. - It results from the drug's interference with **testosterone metabolism** and binding to **androgen receptors**. *Gynaecomastia* - **Gynaecomastia** is a known **endocrine side effect** of **cimetidine** due to its **anti-androgenic activity** and promotion of **prolactin release**. - However, CNS side effects are generally encountered more frequently in clinical practice. *Diarrhea* - **Gastrointestinal side effects** like **diarrhea** are possible with various medications, but they are not the most common or characteristic side effect of **cimetidine**. - Nausea and constipation are also reported, but generally less frequently than CNS effects.

Q: What is the primary use of the combination of atropine and diphenoxylate?

Diarrhea. ***Diarrhea*** - The combination of **diphenoxylate** (an opioid receptor agonist) and a **small amount of atropine** is primarily used to treat diarrhea. - **Diphenoxylate** reduces gut motility, while **atropine** is added to discourage abuse by causing unpleasant anticholinergic side effects at higher doses. *Glaucoma* - **Atropine** is contraindicated in patients with **glaucoma** due to its mydriatic effect, which can worsen angle-closure glaucoma. - The combination is not used to treat glaucoma; glaucoma treatments aim to reduce intraocular pressure. *Iridocyclitis* - **Atropine** can be used in iridocyclitis as a **cycloplegic agent** to prevent synechiae formation and relieve pain. - However, **diphenoxylate** has no role in the treatment of iridocyclitis, making the combination inappropriate for this condition. *Nausea and vomiting* - Some anticholinergic drugs can be used for nausea and vomiting, such as **scopolamine**, but **atropine** is not a primary antiemetic in this context. - **Diphenoxylate**'s primary action is on gut motility for diarrhea, not specifically for nausea and vomiting.

Q: In a clinical setting, for how long are H2 blockers typically prescribed for the treatment of duodenal ulcers?

6 weeks. ***6 weeks*** - H2 blockers are generally prescribed for **6 weeks** for healing uncomplicated duodenal ulcers, which provides adequate time for complete mucosal repair. - This duration is the standard recommendation in most pharmacology textbooks, balancing effective healing with minimizing prolonged medication use. - Studies show that **80-90% of duodenal ulcers heal within 4 weeks**, and extending to 6 weeks ensures complete healing in most cases. *4 weeks* - A 4-week course achieves healing in many duodenal ulcers, but may be insufficient for complete mucosal repair in all patients. - While frequently effective, the **healing rate** at 4 weeks (70-80%) is lower than at 6 weeks, with higher risk of early recurrence. *8 weeks* - An 8-week course exceeds the typical duration needed for uncomplicated duodenal ulcer healing with H2 blockers. - Such prolonged therapy is usually reserved for **complicated ulcers**, **giant ulcers (>2 cm)**, or when initial treatment response is inadequate. - Maintenance therapy for recurrent ulcers may extend to this duration, but not for initial standard treatment. *12 weeks* - A 12-week course is unnecessarily long for duodenal ulcer healing with H2 blockers and is not standard practice. - Extended treatment beyond 8 weeks is typically only considered for **refractory ulcers** that fail standard therapy or for long-term maintenance in specific cases. - Modern practice favors switching to proton pump inhibitors (PPIs) rather than prolonging H2 blocker therapy if healing is inadequate.

Q: Which of the following is the most common adverse effect of omeprazole?

Headache. ***Headache*** - **Headache** is the most frequently reported adverse effect of omeprazole and other proton pump inhibitors (PPIs), occurring in approximately 2-7% of patients. - While generally mild and self-limiting, it is the most common reason for patients to report side effects during PPI therapy. - Other common adverse effects include diarrhea, nausea, and abdominal pain, but headache remains the most prevalent. *Constipation* - Constipation can occur with omeprazole use, but it is less common than headache or diarrhea. - Gastrointestinal side effects like constipation typically occur in a smaller proportion of patients compared to headache. *Liver dysfunction* - Mild **transient elevation of liver enzymes** can occur with omeprazole, but clinically significant liver dysfunction is rare. - Routine monitoring of liver function is generally not required unless there is pre-existing hepatic impairment. *Upper gastrointestinal bleeding* - Omeprazole is used to **treat and prevent** upper gastrointestinal bleeding by reducing gastric acid secretion in conditions like peptic ulcers and erosive esophagitis. - It is a therapeutic agent for this condition, not a causative factor.

Q: Which antiemetic phenothiazine has labyrinthine suppressant activity and is used for vertigo?

Promethazine. ***Promethazine*** - Promethazine is a **phenothiazine derivative** with strong **antihistaminic (H1)** properties, making it highly effective for **labyrinthine suppression** and treatment of vertigo. - It is widely used for **motion sickness, vertigo, and nausea** associated with vestibular disturbances. - Its mechanism combines **dopamine D2 receptor antagonism** (phenothiazine effect) with potent **antihistaminic** and **anticholinergic** actions that specifically suppress vestibular function. - The antihistaminic component is particularly important for labyrinthine suppressant activity. *Prochlorperazine* - While prochlorperazine is a **phenothiazine antiemetic**, it is primarily used for severe nausea and vomiting (migraine, postoperative, chemotherapy-induced). - It has predominantly **dopamine D2 antagonist** activity at the chemoreceptor trigger zone (CTZ) but weaker antihistaminic properties compared to promethazine. - Less commonly used specifically for vertigo compared to promethazine due to weaker vestibular suppressant effects. *Cinnarizine* - While effective for vertigo, cinnarizine is an **antihistamine** and **calcium channel blocker**, not a phenothiazine. - It acts on the **vestibular system** by inhibiting calcium influx into vestibular sensory cells. *Hyoscine* - Hyoscine (**scopolamine**) is an **anticholinergic drug** (not a phenothiazine) effective for motion sickness and some forms of vertigo. - Works by blocking **muscarinic acetylcholine receptors** in the vestibular nuclei.

Q: Which of the following is a guanylate cyclase agonist used in irritable bowel syndrome?

Linaclotide. ***Linaclotide*** - **Linaclotide** is an oral guanylate cyclase-C agonist approved for treating **constipation-predominant irritable bowel syndrome (IBS-C)** and **chronic idiopathic constipation (CIC)** [1]. - It works by increasing intracellular and extracellular **cyclic guanosine monophosphate (cGMP)**, leading to increased fluid secretion into the intestinal lumen and accelerated transit [1]. *Lubiprostone* - **Lubiprostone** is a **chloride channel activator**, specifically type 2 chloride channels, which enhances intestinal fluid secretion [1]. - It is used for **IBS-C** and **CIC**, but its mechanism of action is distinct from guanylate cyclase agonism [1]. *Tegaserod* - **Tegaserod** is a **5-HT4 receptor partial agonist** that was previously used for IBS-C in women [2], [3]. - Its prokinetic effects are mediated through serotonin receptors, not guanylate cyclase pathways [2]. *Methyl naltrexone* - **Methyl naltrexone** is a **peripherally acting mu-opioid receptor antagonist** used to treat **opioid-induced constipation** in advanced illness [1]. - It specifically blocks the constipating effects of opioids without crossing the blood-brain barrier, thus avoiding reversal of central opioid analgesia.

Q: Octreotide is not the primary treatment in:

Glucagonoma. ***Glucagonoma*** - While Octreotide can be used in some cases of Glucagonoma, the primary treatment usually involves **surgical resection** of the tumor. - Its role is often as an **adjunctive therapy** for symptom control, especially for the characteristic rash (necrolytic migratory erythema) and diarrhea, rather than as the primary curative agent. *Variceal bleeding* - Octreotide is a **first-line therapy** for acute variceal bleeding due to its ability to induce splanchnic vasoconstriction. - This action **reduces portal pressure** and blood flow, thereby decreasing bleeding from esophageal varices. *Refractory diarrhea in AIDS* - Octreotide is an effective agent for managing **severe, refractory diarrhea** in patients with AIDS, particularly when conventional antidiarrheal agents fail. - It works by **inhibiting intestinal secretion** and motility, reducing stool output. *Carcinoid syndrome* - Octreotide is the **primary pharmaceutical treatment** for carcinoid syndrome, which is caused by the overproduction of serotonin and other vasoactive substances by neuroendocrine tumors. - It effectively **controls symptoms** such as flushing, diarrhea, and bronchospasm by inhibiting the release of these mediators.

Q: Drugs used for the treatment of acute variceal bleeding include all of the following except:

Desmopressin. ***Desmopressin*** - **Desmopressin (DDAVP)** is a synthetic analog of antidiuretic hormone (ADH) used primarily for conditions like **diabetes insipidus** and bleeding disorders due to its effect on factor VIII and von Willebrand factor. - It does **not directly reduce splanchnic blood flow** or portal pressure, which are the main pharmacological targets for acute variceal bleeding. *Octreotide* - **Octreotide** is a synthetic analog of **somatostatin** that reduces splanchnic blood flow and portal pressure, thereby decreasing variceal bleeding. - It is a **first-line pharmacological agent** for acute variceal hemorrhage. *Somatostatin* - **Somatostatin** is an endogenous hormone that causes **splanchnic vasoconstriction** and reduces portal pressure, making it effective in controlling variceal bleeding. - It has a very **short half-life**, which is why analogs like octreotide are more commonly used clinically. *Terlipressin* - **Terlipressin** is a **vasopressin analog** that causes splanchnic vasoconstriction, leading to a reduction in portal pressure and variceal blood flow. - It is effective in controlling **acute variceal bleeding** and improving survival.

Question 1

Drug that binds bile acids in the intestine and prevents their return to liver via the enterohepatic circulation?

Accepted Answer

Cholestyramine

Answer

Niacin

Answer

Fenofibrate

Answer

Gugulipid

Question 2

Which of the following is classified as an antispasmodic agent?

Accepted Answer

Dicyclomine

Answer

Physostigmine

Answer

Tropicamide

Answer

None of the options

Question 3

Which of the following is the most common side effect of Cimetidine?

Accepted Answer

CNS effects (confusion, dizziness)

Answer

Diarrhea

Answer

Impotence

Answer

Gynaecomastia

Question 4

What is the primary use of the combination of atropine and diphenoxylate?

Accepted Answer

Diarrhea

Answer

Iridocyclitis

Answer

Nausea and vomiting

Answer

Glaucoma

Question 5

In a clinical setting, for how long are H2 blockers typically prescribed for the treatment of duodenal ulcers?

Accepted Answer

6 weeks

Answer

4 weeks

Answer

8 weeks

Answer

12 weeks

Question 6

Which of the following is the most common adverse effect of omeprazole?

Accepted Answer

Headache

Answer

Constipation

Answer

Liver dysfunction

Answer

Upper gastrointestinal bleeding

Question 7

Which antiemetic phenothiazine has labyrinthine suppressant activity and is used for vertigo?

Accepted Answer

Promethazine

Answer

Prochlorperazine

Answer

Cinnarizine

Answer

Hyoscine

Question 8

Which of the following is a guanylate cyclase agonist used in irritable bowel syndrome?

Accepted Answer

Linaclotide

Answer

Tegaserod

Answer

Methyl naltrexone

Answer

Lubiprostone

Question 9

Octreotide is not the primary treatment in:

Accepted Answer

Glucagonoma

Answer

Variceal bleeding

Answer

Refractory diarrhea in AIDS

Answer

Carcinoid syndrome

Question 10

Drugs used for the treatment of acute variceal bleeding include all of the following except:

Accepted Answer

Desmopressin

Answer

Somatostatin

Answer

Terlipressin

Answer

Octreotide

Drugs for Gastrointestinal Diseases — MCQs

Drugs for Gastrointestinal Diseases — MCQs

On this page

Practice by Chapter

Want unlimited practice?